Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Clinical Aggressiveness of Incidental and Non Incidental Thyroid Cancer.

11:30 EDT 23rd July 2014 | BioPortfolio

Summary of "Clinical Aggressiveness of Incidental and Non Incidental Thyroid Cancer."

Background. With the increasing use of thyroid ultrasound, the recognition of thyroid nodules in a large proportion of apparently healthy subjects has become common. Because also the papillary thyroid microcarcinomas (PTMC) are being increasingly discovered, it is important to ascertain whether PTMC may exhibit heterogenous clinical features, associated with different aggressiveness. Aim. We retrospectively examined 122 subjects (98 female, 80.3%, and 24 males) with thyroid cancer to find potential clinical and pathological findings that could be predictive of clinically aggressive behavior. Results. 20 of the 31 patients with true incidental cancer (64.5%) in comparison to 20 of the 91 patients with non incidental cancer (21.9%) had a diameter <10 mm, and this difference was statistically significant (p <0.0001). There was a statistically significant association between size and invasiveness because 19.3% of invasive cancers were smaller than 10 mm whereas 44.6% of non invasive cancers were smaller than 10 mm (p=0.005). The relationship between incidental discovery and invasiveness was also evaluated, but the proportion of incidental invasive cancer (19.3%) was not significantly different than that of incidental non invasive cancer (30.8%). In the multivariate analysis, only size <10 mm (OR=0.35, p=0.013) and papillary vs. other histotypes (OR=0.35, p=0.04) were statistically significant protective factors against invasiveness. Conclusions. (i.) Incidentally discovered thyroid cancers are more frequently microcarcinomas; (ii.) there appears to be no difference in terms of invasive behavior between the incidental and non incidental thyroid cancer; (iii.) smaller tumor size emerges as a protective factor.

Affiliation

Section of Internal Medicine, Endocrinology, Andrology, and Metabolic Disease, University of Bari "Aldo Moro", Bari, Italy. a.ciampolillo@endo.unba.it.

Journal Details

This article was published in the following journal.

Name: Journal of endocrinological investigation
ISSN: 1720-8386
Pages:

Links

PubMed Articles [29863 Associated PubMed Articles listed on BioPortfolio]

Papillary Thyroid Microcarcinoma: How to Diagnose It and How to Manage This Epidemics?

The incidence of papillary thyroid microcarcinoma (PTmC) has been increasing everywhere due to the improvement of imaging and morphological diagnoses and probably also due to environmental alterations...

A case of concurrent several forms of thyroid cancer.

Simultaneous occurrence of papillary and follicular thyroid cancer, known as differentiated thyroid cancer, has been reported with various presentations, but presence of an anaplastic cancer, as an un...

Repositioning therapy for thyroid cancer: new insights on established medications.

Repositioning of established non-cancer pharmacotherapeutic agents with well-known activity and side-effect profiles is a promising avenue for development of new treatment modalities for multiple canc...

Impact of molecular alterations of BRAF in the pathogenesis of thyroid cancer.

BRAF alterations represent a novel indicator of the progression and aggressiveness of thyroid carcinogenesis. So, the main aim of the study was to elucidate the involvement of BRAF gene mutations and...

Update: The Status of Clinical Trials of Kinase Inhibitors in Thyroid Cancer.

Context: Thyroid cancer is usually cured by timely thyroidectomy, however the treatment of patients with advanced disease is challenging, as their tumors are mostly unresponsive to conventional therap...

Clinical Trials [3178 Associated Clinical Trials listed on BioPortfolio]

Collaborative Registry of Patients With Thyroid Cancer and/or Thyroid Tumors

RATIONALE: Gathering information about patients with thyroid cancer or thyroid nodules may help the study of thyroid cancer in the future. PURPOSE: This study is gathering information and...

Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma

Human thyroglobulin (Tg) is the most sensitive biochemical marker for recurrence of differentiated cancer (DTC), especially after the complete removal of thyroid tissue through surgery and...

Studies on Tumors of the Thyroid

Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer. The main purpose of this study is to further understand the methods for...

Assess Vitamin D Levels in Those With & Without Thyroid Cancer

The purpose of this study is to evaluate Vitamin D levels in thyroid cancer patients with active disease compared with thyroid cancer patients in remission and patients with thyroid nodule...

Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer

Background: - Researchers are studying types of thyroid cancer that seem to cluster in families. Non-medullary thyroid cancer accounts for the vast majority of all types of thyroid cancer...

Medical and Biotech [MESH] Definitions

Tumors or cancer of the THYROID GLAND.

Defective development of the THYROID GLAND. This concept includes thyroid agenesis (aplasia), hypoplasia, or an ectopic gland. Clinical signs usually are those of CONGENITAL HYPOTHYROIDISM.

Inflammatory disease of the THYROID GLAND due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-CELLS and thyroid AUTOANTIBODIES. The clinical signs can range from HYPOTHYROIDISM to THYROTOXICOSIS depending on the type of autoimmune thyroiditis.

A thyroid neoplasm of mixed papillary and follicular arrangement. Its biological behavior and prognosis is the same as that of a papillary adenocarcinoma of the thyroid. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1271)

A hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Facial trichilemmomas and papillomatous papules of the oral mucosa are the most characteristic lesions. Individuals with this syndrome have a high risk of BREAST CANCER; THYROID CANCER; and ENDOMETRIAL CANCER. This syndrome is associated with mutations in the gene for PTEN PHOSPHATASE.

Search BioPortfolio: